BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 32073898)

  • 1. Antibacterial and antibiofilm effects of α-humulene against
    Jang HI; Rhee KJ; Eom YB
    Can J Microbiol; 2020 Jun; 66(6):389-399. PubMed ID: 32073898
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibiofilm and antibacterial activities of repurposing auranofin against Bacteroides fragilis.
    Jang HI; Eom YB
    Arch Microbiol; 2020 Apr; 202(3):473-482. PubMed ID: 31705142
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-biofilm and antimicrobial effects of zerumbone against Bacteroides fragilis.
    Kim HR; Rhee KJ; Eom YB
    Anaerobe; 2019 Jun; 57():99-106. PubMed ID: 30953693
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of Probiotic
    Shin DS; Rhee KJ; Eom YB
    J Microbiol Biotechnol; 2020 Mar; 30(3):368-377. PubMed ID: 32066216
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of B. fragilis group and diversity of bft enterotoxin and antibiotic resistance markers cepA, cfiA and nim among intestinal Bacteroides fragilis strains in patients with inflammatory bowel disease.
    Rashidan M; Azimirad M; Alebouyeh M; Ghobakhlou M; Asadzadeh Aghdaei H; Zali MR
    Anaerobe; 2018 Apr; 50():93-100. PubMed ID: 29454108
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Presence of quorum-sensing systems associated with multidrug resistance and biofilm formation in Bacteroides fragilis.
    Pumbwe L; Skilbeck CA; Wexler HM
    Microb Ecol; 2008 Oct; 56(3):412-9. PubMed ID: 18188535
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanisms of Bacteroides fragilis resistance to metronidazole.
    Ghotaslou R; Bannazadeh Baghi H; Alizadeh N; Yekani M; Arbabi S; Memar MY
    Infect Genet Evol; 2018 Oct; 64():156-163. PubMed ID: 29936037
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The prevalence of antibiotic resistance genes in Bacteroides fragilis group strains isolated in different European countries.
    Eitel Z; Sóki J; Urbán E; Nagy E;
    Anaerobe; 2013 Jun; 21():43-9. PubMed ID: 23500457
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bile salts enhance bacterial co-aggregation, bacterial-intestinal epithelial cell adhesion, biofilm formation and antimicrobial resistance of Bacteroides fragilis.
    Pumbwe L; Skilbeck CA; Nakano V; Avila-Campos MJ; Piazza RM; Wexler HM
    Microb Pathog; 2007; 43(2-3):78-87. PubMed ID: 17524609
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro effect of antibiotics on biofilm formation by Bacteroides fragilis group strains isolated from intestinal microbiota of dogs and their antimicrobial susceptibility.
    Silva JO; Martins Reis AC; Quesada-Gómez C; Pinheiro AQ; Freire RS; Oriá RB; de Carvalho CB
    Anaerobe; 2014 Aug; 28():24-8. PubMed ID: 24799339
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efflux pump overexpression in multiple-antibiotic-resistant mutants of Bacteroides fragilis.
    Pumbwe L; Glass D; Wexler HM
    Antimicrob Agents Chemother; 2006 Sep; 50(9):3150-3. PubMed ID: 16940115
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The underappreciated in vitro activity of tedizolid against Bacteroides fragilis species, including strains resistant to metronidazole and carbapenems.
    Goldstein EJ; Citron DM; Tyrrell KL; Leoncio ES; Merriam CV
    Anaerobe; 2017 Feb; 43():1-3. PubMed ID: 27713022
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Can meropenem E-test be used to estimate the presence of carbapenem resistance gene cfiA among Bacteroides fragilis strains?].
    Toprak Ülger N; Ilki A; Ozel N; Balkan N; Söyletir G
    Mikrobiyol Bul; 2011 Jul; 45(3):385-91. PubMed ID: 21935771
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antimicrobial susceptibility testing of Bacteroides fragilis using the MALDI Biotyper antibiotic susceptibility test rapid assay (MBT-ASTRA).
    Justesen US; Acar Z; Sydenham TV; Johansson Å;
    Anaerobe; 2018 Dec; 54():236-239. PubMed ID: 29501419
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Susceptibility patterns and characterization of beta-lactamases in clinical isolates of Bacteroides fragilis.
    Mastrantonio P; Spigaglia P; Sebastianelli A
    Eur J Clin Microbiol Infect Dis; 1994 Jun; 13(6):475-80. PubMed ID: 7957267
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inactivation of MarR gene homologs increases susceptibility to antimicrobials in Bacteroides fragilis.
    Silva CMG; Silva DNDS; Costa SBD; Almeida JSS; Boente RF; Teixeira FL; Domingues RMCP; Lobo LA
    Braz J Microbiol; 2018; 49(1):200-206. PubMed ID: 28847541
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lessons learned from the anaerobe survey: historical perspective and review of the most recent data (2005-2007).
    Snydman DR; Jacobus NV; McDermott LA; Golan Y; Hecht DW; Goldstein EJ; Harrell L; Jenkins S; Newton D; Pierson C; Rihs JD; Yu VL; Venezia R; Finegold SM; Rosenblatt JE; Gorbach SL
    Clin Infect Dis; 2010 Jan; 50 Suppl 1():S26-33. PubMed ID: 20067390
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Occurrence of enterotoxigenic and nonenterotoxigenic Bacteroides fragilis in calves and evaluation of their antimicrobial susceptibility.
    Almeida FS; Nakano V; Avila-Campos MJ
    FEMS Microbiol Lett; 2007 Jul; 272(1):15-21. PubMed ID: 17488333
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multidrug-resistant Bacteroides fragilis group on the rise in Europe?
    Hartmeyer GN; Sóki J; Nagy E; Justesen US
    J Med Microbiol; 2012 Dec; 61(Pt 12):1784-1788. PubMed ID: 22956754
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of trends in antimicrobial resistance patterns among clinical isolates of Bacteroides fragilis group species from 1990 to 1994.
    Snydman DR; McDermott L; Cuchural GJ; Hecht DW; Iannini PB; Harrell LJ; Jenkins SG; O'Keefe JP; Pierson CL; Rihs JD; Yu VL; Finegold SM; Gorbach SL
    Clin Infect Dis; 1996 Dec; 23 Suppl 1():S54-65. PubMed ID: 8953108
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.